# iPACK Block for Total Knee Arthroplasty

> **NCT06087562** · PHASE4 · UNKNOWN · sponsor: **Poznan University of Medical Sciences** · enrollment: 350 (estimated)

## Conditions studied

- Knee Osteoarthritis
- Knee Pain Chronic
- Knee Disease

## Interventions

- **DRUG:** Ropivacaine 0.5% Injectable Solution 20mL
- **DRUG:** 0,9% normal saline 20mL

## Key facts

- **NCT ID:** NCT06087562
- **Lead sponsor:** Poznan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-16
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2023-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06087562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06087562, "iPACK Block for Total Knee Arthroplasty". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06087562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*